1993
DOI: 10.1093/oxfordjournals.aje.a116616
|View full text |Cite
|
Sign up to set email alerts
|

Correlates of Postmenopausal Estrogen Use and Trends through the 1980s in Two Southeastern New England Communities

Abstract: Correlates and prevalence of current postmenopausal estrogen use were examined in two southeastern New England communities for the period 1981 through 1990. Data were obtained from five biennial cross-sectional household health surveys, with current use of postmenopausal estrogen determined by inspection of medication bottles. Analysis included 3,279 women aged 40-64 years, of whom 2,215 (67.6%) were postmenopausal. The prevalence of estrogen use among all postmenopausal women increased from 5.3% (95% confiden… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
42
3
1

Year Published

1997
1997
2007
2007

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 124 publications
(51 citation statements)
references
References 0 publications
5
42
3
1
Order By: Relevance
“…For a factor to confound an association, though, it needs to be associated with the exposures of interest, here postmenopausal oestrogen and SHBG levels, in addition to being associated with disease. Women who use hormone replacement therapy tend to be leaner, suggesting that they may have lower oestrogen levels than women who do not use them (Derby et al, 1993). However, in our dataset there was no evidence of a difference in age-adjusted levels of sex hormones or SHBG between control subjects who had and had not used hormone replacement therapy.…”
Section: Discussioncontrasting
confidence: 54%
“…For a factor to confound an association, though, it needs to be associated with the exposures of interest, here postmenopausal oestrogen and SHBG levels, in addition to being associated with disease. Women who use hormone replacement therapy tend to be leaner, suggesting that they may have lower oestrogen levels than women who do not use them (Derby et al, 1993). However, in our dataset there was no evidence of a difference in age-adjusted levels of sex hormones or SHBG between control subjects who had and had not used hormone replacement therapy.…”
Section: Discussioncontrasting
confidence: 54%
“…The strongest biological determinant of use of HT is surgical menopause (Derby et al 1993;Egeland et al 1988;Standeven et al 1986;Stadel and Weiss 1975;Rosenberg et al 1979;Johannes et al 1994). The presence of menopausal symptoms, such as hot flashes and excessive sweating, are other biological factors found to be correlated with HT use (Stadel and Weiss 1975;Johannes et al 1994).…”
Section: The Correlates Of Hormone Therapymentioning
confidence: 99%
“…The presence of menopausal symptoms, such as hot flashes and excessive sweating, are other biological factors found to be correlated with HT use (Stadel and Weiss 1975;Johannes et al 1994). Health behavior indicators, such as exercise, alcohol consumption, smoking, and body mass index have also been associated with HT (Egeland et al 1988;Johannes et al 1994;Stampfer and Colditz 1991;Matthews et al 1996a;Barrett-Connor, Wingard, and Criqui 1989;Derby et al 1993). However, it seems unlikely that these behaviors actually cause HT use.…”
Section: The Correlates Of Hormone Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…46 In contrast, one quarter of the white women had been offered HRT, but their attitudes toward medical intervention tended to be less favorable with increasing education; our findings are limited by the fairly homogeneously welleducated sample. Some studies suggest that college-educated women are more likely to attribute psychological symptoms to life stressors than a biomedical model and prefer "natural therapy" to HRT 30 ; that they are more concerned about the potential risk of breast cancer than of heart disease, and rate their risk of breast cancer far higher 27 ; and that perceived risk of malignancy plays a much greater role in women's decisions about HRT than perceived risk of menopause-related sequelae. 47 The latter was corroborated in focus groups.…”
Section: Discussionmentioning
confidence: 99%